Read the FDA’s recommendations related to Accolade pacemaker devices by Boston Scientific and a potential need for early device replacement.
Similar Posts
Aurobindo Pharma Limited, Unit VII – 2/10/2026
Aurobindo Pharma Limited, Unit VII – 2/10/2026. 1/27/2023. Country: India. Record Type: 483IndulgeRx Brands, Inc – 703668 – 06/16/2025
New Drug/MisbrandedHartford Bakery, Inc. Issues Allergy Alert on Undeclared Hazelnuts in “Lewis Bake Shop Artisan Style ½ Loaf”
Hartford Bakery, Inc. is voluntarily recalling six lots of its “Lewis Bake Shop Artisan Style 1/2 Loaf” as this product may contain undeclared hazelnuts. People with a nut allergy or severe sensitivity to hazelnuts run the risk of serious or life-threatening allergic reactions if they consume theseDrug Safety Communications
FDA Drug Safety Communications connect consumers and health care professionals to important drug safety information. The webpage contains the most recent Drug Safety Communications from FDA as well as links for Early Communications, Follow-Up Early Communications, Information for Healthcare ProfessiGDUFA Implementation Quarterly Meetings between FDA and Industry
FDA and representatives of the generic drug industry meet quarterly to discuss topics related to the implementation of GDUFA.Fuentes Farms, LLC Recalls Product Because of Possible Health Risk
Fuentes Farms of McAllen, Texas is recalling 71 Boxes of Fresh Cucumbers, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy
